Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Waystar HoldingWAY -1.59%14 Days Sales Outstanding is 51.15 as of Jun. 2026, which is 4% below its 10-year median of 53.50. GuruFocus rates WAY with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Waystar Holding ranks worse than 54.82% on this metric.
The historical rank and industry rank for Waystar Holding's Days Sales Outstanding or its related term are showing as below:
WAY'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.93 Med: 53.5 Max: 58.18
Current: 49.93
During the past 5 years, Waystar Holding's highest Days Sales Outstanding was 58.18. The lowest was 49.93. And the median was 53.50.
WAY's Days Sales Outstanding is ranked worse than 54.82% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs WAY: 49.93
Waystar Holding's Days Sales Outstanding
increased
from Jun. 2025 (49.02) to Jun. 2026 (51.15).
Waystar Holding (NAS:WAY) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Waystar Holding Days Sales Outstanding Related Terms
Waystar Holding Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Waystar Holding's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAY vs DOCS, HTFL, HNGE: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Waystar Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Waystar Holding Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Waystar Holding's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Waystar Holding's Days Sales Outstanding falls into.
Waystar Holding Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Waystar Holding (WAY) has a Days Sales Outstanding of 51.15 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Waystar Holding and its competitors. This is near median its historical median of 53.50. Over the past decade, Waystar Holding's Days Sales Outstanding has ranged from 49.93 to 58.18. According to the industry distribution chart, Waystar Holding ranks #364 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 54.8%.
Is Waystar Holding's Days Sales Outstanding too high?
Waystar Holding's current Days Sales Outstanding of 51.15 is near median its 10-year median of 53.50. Over the past 10 years, this metric has ranged from a low of 49.93 to a high of 58.18. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Waystar Holding's value of 51.15 is 11.7% above this industry median. Based on the distribution chart, Waystar Holding ranks #364 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Waystar Holding has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Waystar Holding's Days Sales Outstanding compare to DOCS and HTFL?
According to the Healthcare Providers & Services industry distribution chart, Waystar Holding ranks #364 out of 664 companies for Days Sales Outstanding. This places Waystar Holding in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Waystar Holding's value of 51.15 is 11.7% above this benchmark. Historically, Waystar Holding's own Days Sales Outstanding has ranged from 49.93 to 58.18 over the past decade. While the company's 10-year median is 53.50 vs. the industry median of 45.78, Waystar Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Waystar Holding's current Days Sales Outstanding of 51.15 is 11.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Waystar Holding and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Waystar Holding's current Days Sales Outstanding is 51.15, which is near median its own 10-year median of 53.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waystar Holding stock overvalued right now?
Waystar Holding (WAY) has a current Days Sales Outstanding of 51.15. The current Days Sales Outstanding is 51.15, which is near median its 10-year median of 53.50 and 11.7% above the Healthcare Providers & Services industry median of 45.78. Waystar Holding's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Waystar Holding (WAY), the current Days Sales Outstanding is 51.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
14GF Score
Get the complete analysis for WAY
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAY has been successfully added to your 
